U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843693) titled 'A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers' on Sept. 22.
Brief Summary: This is a Phase 1, open label, five arm study to evaluate the pharmacodynamic effects of multiple doses of upadacitinib, tofacitinib, and baricitinib in healthy adult participants.
Study Start Date: Aug. 26
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: Upadacitinib
Oral Tablet
DRUG: Tofacitinib
Oral Tablet
DRUG: Baricitinib
Oral Tablet
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Service...